Breeze Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Breeze Bio, Inc. - overview
Established
2016
Location
Brisbane, CA, US
Primary Industry
Biotechnology
About
Breeze Bio, Inc. formerly known as GenEdit is a biotechnology company founded in 2016 and based in California, US. The company develops the NanoGalaxy platform, an in vivo genetic medicine delivery system that uses proprietary non‑lipid, hydrophilic polymer nanoparticles to enable targeted delivery of nucleic acid therapeutics beyond the liver. Breeze Bio was co‑founded by Kunwoo Lee, who serves as CEO, and Hyo Min Park, who serves as COO.
In February 2026, Breeze Bio, Inc. raised USD 34. 20 million in series B funding co‑led by Yuanta Investment and returning investor DSC Investment, with participation from other new investors SV Investment, Kiwoom Investment, STIC Ventures, and Top Harvest Capital. Returning investors DAYLI Partners, WOORI Venture Partners, KDB Bank, Pathway Investment, Loftyrock Investment, Korea Investment Partners, and ACVC Partners, and other unspecified investors also participated in the round.
The funding is to expedite the expansion of its delivery platform and further advance its internal therapeutic programs.
Current Investors
Hong Shan, SK, DCVC
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories
Website
www.breezebio.com
Verticals
HealthTech, Nanotechnology
Company Stage
Series B
Total Amount Raised
Subscriber access only
Breeze Bio, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.